Post-Market Phase

This chapter deals with regulatory controls in the post-market

phase, which commences once a therapeutic product obtains mar-

keting authorization (regulatory approval). Topics covered include

preparing for a product launch, maintaining continued compliance

for the established markets, change controls and vigilance and

adverse event reporting. This chapter concludes with a discussion

of key performance indicators relevant to regulatory processes.